Log In
BCIQ
Print this Print this
 

CR6970

  Manage Alerts
Collapse Summary General Information
Company Mylan N.V.
DescriptionSelective kinase inhibitor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard IndicationOsteoarthritis
Indication DetailsTreat osteoarthritis (OA)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today